Sabatinelli G
WHO Regional Office for Europe, Copenhagen.
Med Parazitol (Mosk). 2000 Apr-Jun(2):4-8.
The number of indigenous malaria cases in European region peaked in 1997, when 77,985 cases were officially reported. These were caused almost exclusively by P. vivax, P. falciparum being restricted to a rather limited number of cases in Tajikistan only. Another important problem in the European Region is the importation of malaria associated with a high fatality rate from tropical endemic countries. There were 841 cases of malaria in Armenia, 567 of which were locally transmitted, 30 out of 81 districts recorded malaria cases. 89% of the indigenous cases were registered in Masis district, in the Ararat valley. In 1998, total number of cases increased to 1156. Of the 542 indigenous cases registered, 376 were in Masis district. 9911 cases were officially reported in 1997 in Azerbaijan and 5175 cases in 1998. Approximately half of malaria cases were reported from seven districts: Nakhichivan (10.4%), Imishli (14.6%), Fizuli (8.1%), Sabirabad (6.8%), Saatly (6%), Bejlagan (5.6%) and Bilasuvar (4.8%). Local transmission is also reported from the periurban areas of Baku, where many displaced people are living in temporary shelters. In 1997, a total of 30,054 malaria cases were officially registered in Tajikistan, of which 85.3% occurred in the Khatlon region, 10.5% in Dushanbe region, 3.5% in Gorno-Badakhshan region and 0.7% in Leninabad region. Following implementation of malaria control activities with WHO assistance, the number of malaria cases officially registered in 1998 dropped to 19,361 (187 were cases of falciparum malaria). A dramatic change occurred in malaria situation in Turkmenistan in 1998, when 115 indigenous cases were registered. The majority of malaria cases (104) were registered in the Kushka district, in south-east of Turkmenistan, among military service personnel. In recent years, the Government of Turkey has renewed its efforts to fight malaria, incorporating them into GAP with support from UNDP and WHO. In 1998, 36,451 cases were reported, 87.1% from southeastern Anatolia, 8.7% from Adana area and 4.2% from other areas of Turkey. The epidemics in Armenia, Azerbaijan, Tajikistan and Turkey are having a considerable impact on the malaria situation in neighbouring countries of the European Region. Malaria cases have been imported from Turkey mainly to western Europe; from Azerbaijan to the Russian Federation, Georgia, and the Republic of Moldova; and from Tajikistan to the central Asian republics and to the Russian Federation. WHO made all possible efforts to mobilize and coordinate assistance from international community. WHO/EURO organized missions to those NIS where there is a risk of malaria epidemics. Most of the very limited funds reserved for epidemic prevention and control were immediatelly used to provide a limited stock of antimalarial drugs and to help the national institutions in Kazakhstan and Uzbekistan implement antimalarial activities. In 1997, with the financial support of the Italian Government and the technical assistance of the Instituto Superiore di Sanità in Rome (WHO collaborating centre for research and training in planning tropical disease control) and of the Martsinovsky Institute of Medical Parasitology and Tropical Medicine in Moscow (WHO collaborating centre on vivax malaria), the training of health personnel in the field of malaria diagnosis, treatment and control was initiated in Armenia, Azerbaijan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. In 1996-1997, Japan provided financial support for a large malaria control project in Tajikistan, and Norway supported activities carried out in 1997 to tackle the malaria outbreak in Armenia. In 1997-1998, Italy supported malaria prevention activities in Kazakhstan, Kyrgyzstan and Uzbekistan, and some of the malaria activities carried out in Tajikistan under the integrated Management of Childhood Illness initiative. Several training courses and seminars were carried out in Turkey in 1998 by the national malaria contro
欧洲区域本土疟疾病例数在1997年达到峰值,当年官方报告了77985例。这些病例几乎全部由间日疟原虫引起,恶性疟原虫仅局限于塔吉克斯坦数量相当有限的病例。欧洲区域的另一个重要问题是从热带流行国家输入的疟疾,其死亡率很高。亚美尼亚有841例疟疾病例,其中567例为本地传播,81个地区中有30个记录到疟疾病例。89%的本土病例登记在阿拉拉特山谷的马西斯区。1998年,病例总数增至1156例。在登记的542例本土病例中,376例在马西斯区。1997年阿塞拜疆官方报告了9911例疟疾病例,1998年为5175例。约一半的疟疾病例来自七个地区:纳希切万(10.4%)、伊米什利(14.6%)、菲祖利(8.1%)、萨比拉巴德(6.8%)、萨特利(6%)、贝伊拉甘(5.6%)和比拉苏瓦尔(4.8%)。巴库周边地区也报告了本地传播情况,那里有许多流离失所者居住在临时住所。1997年,塔吉克斯坦官方共登记了30054例疟疾病例,其中85.3%发生在哈特隆地区,10.5%在杜尚别地区,3.5%在戈尔诺-巴达赫尚地区,0.7%在列宁纳巴德地区。在世卫组织的协助下开展疟疾控制活动后,1998年官方登记的疟疾病例数降至19361例(其中187例为恶性疟疾病例)。1998年土库曼斯坦的疟疾情况发生了巨大变化,登记了115例本土病例。大多数疟疾病例(104例)登记在土库曼斯坦东南部的库什卡区,患者为军人。近年来,土耳其政府重新加大了抗击疟疾的力度,在开发署和世卫组织的支持下将其纳入了《东南安纳托利亚项目》。1998年报告了36451例病例,87.1%来自东安纳托利亚,8.7%来自阿达纳地区,4.2%来自土耳其其他地区。亚美尼亚、阿塞拜疆、塔吉克斯坦和土耳其的疫情对欧洲区域邻国的疟疾情况产生了相当大的影响。疟疾病例主要从土耳其输入西欧;从阿塞拜疆输入俄罗斯联邦、格鲁吉亚和摩尔多瓦共和国;从塔吉克斯坦输入中亚各共和国和俄罗斯联邦。世卫组织尽一切可能努力动员和协调国际社会的援助。世卫组织欧洲区域办事处向有疟疾流行风险的独联体国家派出了特派团。为疫情防控预留的非常有限的资金大部分立即用于提供有限的抗疟药品库存,并帮助哈萨克斯坦和乌兹别克斯坦的国家机构开展抗疟活动。1997年,在意大利政府财政支持以及罗马高等卫生研究院(世卫组织热带病控制规划研究和培训合作中心)和莫斯科马尔季诺夫斯基医学寄生虫学和热带医学研究所(世卫组织间日疟合作中心)的技术援助下,在亚美尼亚、阿塞拜疆、哈萨克斯坦、吉尔吉斯斯坦、塔吉克斯坦、土库曼斯坦和乌兹别克斯坦启动了疟疾诊断、治疗和控制领域的卫生人员培训。1996 - 1997年,日本为塔吉克斯坦的一个大型疟疾控制项目提供了财政支持,挪威支持了1997年为应对亚美尼亚疟疾疫情而开展的活动。1997 - 1998年,意大利支持了哈萨克斯坦、吉尔吉斯斯坦和乌兹别克斯坦的疟疾预防活动,以及在塔吉克斯坦根据儿童疾病综合管理倡议开展的一些疟疾活动。1998年土耳其国家疟疾防治部门举办了几次培训课程和研讨会